Why the study?
What are the outcomes and prognostic factors for patients with synovial sarcoma treated at a single institution?
What are the outcomes and prognostic factors for patients with synovial sarcoma treated at a single institution?
In patients with localized synovial sarcoma, a good rate of cure can be achieved with surgery, with age, size, histology, and radiotherapy influencing prognosis.
Answers are grounded in this paper and cite their sources.
Stage strongly predicts survival in synovial sarcoma; supports surgery for localized disease but leaves open systemic options for metastatic cases.
BACKGROUND: The optimal treatment for synovial sarcoma remains controversial. Treatment, outcome, and prognostic factors in patients treated in a single institution were examined. METHODS: Synovial sarcoma patients who underwent surgery at the Rizzoli Institute between 1976 and 2006 were identified and analyzed. RESULTS: Characteristics of the 250 patients (128 female; 122 male) included: median age, 37 years (range, 7-83 years); 177 (71%) with tumors in the lower extremity, 40 (16%) with tumors in the upper extremity, and 33 with tumors in the trunk (13%); primary lesion size >5 cm in 121 patients (55%); and 204 (82%) patients with localized disease and 46 (18%) with metastatic disease at the time of presentation. All patients with localized disease underwent surgery. Twenty-four percent of patients underwent amputation. Adequate surgical margins were achieved in 88% patients. In patients with localized disease, radiotherapy was administered to 103 (50%) patients, and chemotherapy to 98 (48%). With a median follow-up of 5.5 years (range, 1-30 years), the 5-year overall survival rate was 10% for patients with metastatic disease and 76% for patients with localized disease (P = .0001). The 5-year event-free survival was 58% in patients with localized disease. Multivariate analysis indicated that size, age, histologic subtype, and the use of radiotherapy were independent factors for event-free survival. CONCLUSIONS: In those patients with localized disease, a good rate of cure can be achieved. Age, size, histology, and use of radiotherapy influence prognosis, whereas to the authors' knowledge, the role of adjuvant chemotherapy remains unproven.
No takes yet. Share an insight, caveat, or question.
Palmerini et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: